Shanghai Zerun Biotechnology Co.,Ltd
Registry sponsor category
Industry
- Other names
- Shanghai Zerun Biotechnology Co.,Ltd
- Company name
- Shanghai Zerun Biotechnology Co.,Ltd
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (12)
- A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
- A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine
- Evaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy Females
- Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females
- Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.
- Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females
- Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women
- Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females
- Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19
- Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19
- Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9
- Safety and Immunogenicity of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19